Polyclonal Anti-MLL

Price

200.00 USD

Size

100ug/vial

Reactivities

Hum, Mouse

Format

Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3.

References

1. Armstrong, S. A., Staunton, J. E., Silverman, L. B., Pieters, R., den Boer, M. L., Minden, M. D., \nSallan, S. E., Lander, E. S., Golub, T. R., Korsmeyer, S. J. MLL translocations specify a distinct \ngene expression profile that distinguishes a unique leukemia. Nature Genet. 30: 41-47, 2002.\n2. Bruch, J., Wilda, M., Teigler-Schlegel, A., Harbott, J., Borkhardt, A., Metzler, M. Occurrence of \nan MLL/LAF4 fusion gene caused by the insertion ins(11;2)(q23;q11.2q11.2) in an infant with acute \nlymphoblastic leukemia. (Letter) Genes Chromosomes Cancer 37: 106-109, 2003.\n3. Caligiuri, M. A., Strout, M. P., Oberkircher, A. R., Yu, F., de la Chapelle, A., Bloomfield, C. D. The \npartial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 \nis restricted to one chromosome. Proc. Nat. Acad. Sci. 94: 3899-3902, 1997.

Storage Temp

At -20 degree C for one year. After reconstitution, at 4 degree C for one month. It can also be aliquotted and stored frozen at -20 degree C for a longer time.Avoid repeated freezing and thawing.

Scientific Background

MLL(Myeloid/lymphoid or mixed Lineage Leukemia gene),also called MLL1, ALL1 or CXX7, is a \nfrequent target for recurrent translocations in acute leukemias that may be characterized as acute \nmyeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or mixed lineage (biphenotypic) leukemia\n(MLL). The MLL gene encodes a DNA-binding protein that methylates histone H3 lys4 (H3K4) and \npositively regulates expression of target genes, including multiple HOX genes. The MLL gene is \nmapped on 11q23.3. A leukemogenicMLL fusion protein that activates HOX expression had no effect on \nhistone methylation, suggesting a distinct mechanism for gene regulation by MLLand MLL fusion \nproteins. The MLL gene encodes a large nuclear protein that is required for the maintenance of HOX \ngene expression. MLL is cleaved at 2 conserved sites to generate an N-terminal 320-kD fragment \n(N320) and a C-terminal 180-kD fragment (C180), which heterodimerize to stabilize the complex and \nconfer its subnuclear destination. RNA interference-mediated knockdown of taspase-1 in HeLa cells \nresulted in the appearance of unprocessed MLL and the loss of proper HOX gene expression.